{
    "ticker": "SCLXW",
    "name": "Scilex Holding Company",
    "description": "Scilex Holding Company is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of pain and related conditions. Founded in 2015, Scilex aims to advance the treatment of patients suffering from chronic pain through its proprietary and novel pain management solutions. The company is known for its lead product candidate, ZTlido (lidocaine topical system), which is designed to provide localized pain relief without the side effects associated with systemic medications. Scilex is committed to improving the quality of life for patients through the development of therapeutic options that address unmet medical needs. With a robust pipeline of product candidates, the company is dedicated to research and development efforts that support the advancement of pain management therapies. Scilex operates with a strong emphasis on innovation and collaboration, seeking to partner with healthcare providers and organizations to maximize patient access to its therapies. The company's vision is to redefine the future of pain management and provide comprehensive solutions that enhance patient outcomes.",
    "industry": [
        "Biopharmaceuticals",
        "Healthcare"
    ],
    "headquarters": "San Diego, California, USA",
    "founded": "2015",
    "website": "https://www.scilexholding.com",
    "ceo": "Nasrat Hakim",
    "social_media": {
        "twitter": "https://twitter.com/ScilexHolding",
        "linkedin": "https://www.linkedin.com/company/scilex-holding-company/"
    },
    "investor_relations": "https://ir.scilexholding.com",
    "key_executives": [
        {
            "name": "Nasrat Hakim",
            "position": "CEO"
        },
        {
            "name": "Michael A. Dyer",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Pain Management",
            "products": [
                "ZTlido"
            ]
        }
    ],
    "seo": {
        "meta_title": "Scilex Holding Company | Innovative Pain Management Solutions",
        "meta_description": "Explore Scilex Holding Company, a leader in biopharmaceuticals focused on innovative pain therapies. Discover ZTlido and our commitment to improving patient care.",
        "keywords": [
            "Scilex",
            "Pain Management",
            "ZTlido",
            "Chronic Pain",
            "Biopharmaceuticals"
        ]
    },
    "faq": [
        {
            "question": "What is Scilex known for?",
            "answer": "Scilex is known for developing innovative therapies for pain management, particularly its lead product ZTlido."
        },
        {
            "question": "Who is the CEO of Scilex?",
            "answer": "Nasrat Hakim is the CEO of Scilex Holding Company."
        },
        {
            "question": "Where is Scilex headquartered?",
            "answer": "Scilex is headquartered in San Diego, California, USA."
        },
        {
            "question": "What is ZTlido?",
            "answer": "ZTlido is a lidocaine topical system developed by Scilex for localized pain relief."
        },
        {
            "question": "When was Scilex founded?",
            "answer": "Scilex was founded in 2015."
        }
    ],
    "competitors": [
        "PFE",
        "JNJ",
        "AMGN",
        "ABBV"
    ],
    "related_stocks": [
        "MRNA",
        "GILD",
        "BMY",
        "VRTX"
    ]
}